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ABSTRACT
EVALUATION OF HORIZONTAL GENE TRANSFER BETWEEN GENETICALLY
ENGINEERED CYANOBACTERIA AND GRAM-NEGATIVE BACTERIA
Andriana Chrysovalanti Zourou
Old Dominion University, 2021
Co-Directors: Dr. Lesley H. Greene
Dr. James W. Lee

As the world population is increasing and societies become more technology driven,
there is an imperative to develop ‘green energy’ sources to protect our planet. Cyanobacteria that
have been genetically engineered to produce organic compounds that may be burnt as fuels show
great potential, as they are an environmentally friendly and self-renewable, net carbon-neutral
option. However, there are potential risks in the development and use of genetically modified
organisms (GMOs). We need to understand in advance the risks that GMOs may pose to our
environment and to animal and human health. This will enable experimental procedures,
containment strategies and policies to be developed to prevent accidents and eliminate potential
harmful effects of GMOs in the environment such as sharing antibiotic genes to native
microorganisms. My research seeks to assess the bio-risk posed by engineered cyanobacteria and
their capability of transferring genes of antibiotic resistance to other bacteria, they may encounter
in their environment outside of laboratory conditions. Here genetically engineered (GE)
cyanobacteria that contain antibiotic resistance genes commonly used as selective markers, are
being studied and their ability to horizontally transfer to wild-type bacterial strains. In aim one,
the plasmid vector that carries the transgenes to confer antibiotic resistance and to theoretically
produce biofuel was introduced into the cyanobacteria, Thermosynechococcus elongatus BP1
and select other gram-negative bacterial strains, Escherichia coli K12, Escherichia coli DH5α,

and Pseudomonas putida KT2440, to assess their ability to carry the plasmid and obtain
antibiotic resistance. In the second aim, the ability for the plasmid to undergo horizontal gene
transfer (HGT), from GE cyanobacteria to two different strains of E. coli was determined. In the
third aim, the ability of P. putida KT2440 to uptake the plasmid via HGT from GE cyanobacteria
was studied. This research also examines the fundamental mechanisms of horizontal gene
transfer, which is foundational to microbial life and not completely understood. The results
reveal that HGT occurs between our model cyanobacteria and E. coli strains but not
Pseudomonas. This research provides foundational knowledge to help develop policies and
safeguards for the safe design and use of GMOs.
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CHAPTER I
INTRODUCTION

Genetic Engineering with Synthetic Biology
The recent advances in genetic engineering have made it a fascinating field to be working
in today. Especially with the discovery and development of modern gene editing tools such as
the gene editing CRISPR/ Cas9 system, for which Emmanuelle Charpentier and Jennifer Doudna
were recently awarded the Nobel Prize,1 the possibilities for providing solutions to modern world
problems through genetic engineering are seemingly endless. Medicine, industry, and
agriculture all stand to benefit from employing genetic editing techniques for solutions to
problems. At the same time, as promising as gene editing may be, the implications of
permanently altering an organism’s genome, both for the organism as well as its environment,
remain unknown. Therefore, it is imperative that more research is done towards investigating this
parameter.
An area where genetic engineering techniques show great promise is in the modification
of cyanobacteria to produce biofuel. This is due to their unique capability of utilizing inorganic
carbon --in the form of CO2-- from their environment to produce organic products, with fast
doubling times, while requiring little maintenance. This feature, combined with environmental
concerns over the excess amounts of on CO2 currently found in the atmosphere, make genetically
engineered (GE) cyanobacteria that have the ability to produce organic molecules to be used as
fuel, a promising avenue to be explored.
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GE Cyanobacteria for Biofuels
Currently, 85% of the world energy demand relies on the consumption of fossil fuels2 It
is to this day a profitable and expanding field that, according to the U.S. Energy Information
Administration increased production by 12% from 2017 to 2018.3 However, it is a finite resource
and the scenario of having to compete for diminishing oil reserves is a cause for great concern.
For this reason, alternative fuel sources from natural, renewable reserves have been explored as
options for being ultimately integrated in our daily lives. Examples of such renewable resources
include solar, wind, hydroelectric and biomass energy. Of these, biomass is one that has the
ability to make use of local energy supply, without the need of transportation. For this reason, it
has been used in developing, non-industrialized countries to fuel local energy demand.4
Biofuel is energy derived from biological sources. When considering its application and
integration to the engines we use today, the ideal biofuel can be used without major engine
modifications. To achieve this, biofuel has mostly been produced in the form of biodiesel or
bioethanol, which require little modification to some the engines we already use.2 However, this
is where the challenges of biofuel come into play. It is desirable to produce biofuel with certain
characteristics so as to compete with the quality and energy produced from the combustion of
fossil fuels. Bioethanol is a fossil fuel alternative that is largely produced from microbial
fermentation of sugar or starch-rich plant, such as corn or sugarcane. When supplemented with
gasoline, up to 85% (v/v) bioethanol can be used in engines without requiring modification to
vehicles.5 Limitations arise from the need of arable land and water required for the plants used in
the bioethanol production process to grow on. Proposed methods of making production of
bioethanol more sustainable involve the addition of chemical pretreatment to aid with the
decomposition of the plants’ biomass and water reutilization of the evaporators.6-8 However, the
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fact that bioethanol has a low energy density makes essential the need to turn to other fuel
alternatives. Longer carbon chains than the well-studied bioethanol make for higher biofuel
quality, as C-C bonds have higher energy content. Furthermore, higher energy density allows for
easier and more efficient energy transportation as more energy can be transported or stored at a
given volume.9 For this reason, biofuel engineering has shifted towards the production of
molecules with longer chain hydrocarbons.
Around the world laboratories in both academia and industry are researching the
production of high energy compounds for biofuel production. The main approach is genetic
engineering of microorganisms. They do not require vast areas of land for their growth, have
faster doubling times that plants, and their genomes are easier to manipulate. As with all major
emerging fields, however, the ramifications to our environment, as well as animal and human
health must be thoughtfully understood. This is the goal of USDA funded work, that has led to a
collaborative project between Dr. Lee’s and Dr. Greene’s lab at Old Dominion University. A
vital part of that project is evaluating the biosafety of the GE cyanobacteria with genes
associated with biofuel production and antibiotic resistance. The engineered plasmid designed to
be introduced into cyanobacteria includes a butanol dehydrogenase and a keto-acid
decarboxylase gene intended to utilize the cyanobacteria’s intrinsic metabolic pathways to the
production of biofuel and also includes genes conferring antibiotic resistance to the transformed
cyanobacteria as selection markers in the cloning process. The pUC57 vector, that is used for the
construction of the plasmid to be transformed into the cyanobacteria, carries a gene for
ampicillin resistance, while the constructed cassette contains a gene conferring kanamycin
resistance. Thus, the transformed cyanobacteria can be selected based on their ability to grow on
media supplemented with antibiotics. Conferring onto the cyanobacteria tolerance to antibiotics
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can potentially lead to health concerns when taking into account that if these GE cyanobacteria
are released in the environment, they may pass these genes to other microorganisms that they
encounter. The horizontal gene transfer (HGT) of these genes upon interaction of the GE
cyanobacteria with other bacterial types is the focus of this thesis.

Antibiotics
Antibiotics are naturally secreted substances by bacteria in small amounts, constituting for
1.6% among microbial products.10 The modern era of antibiotics began in 1929 with the first report
on the discovery of penicillin by Alexander Fleming.11, 12 Synthetically made antibiotics have since
been a standard method of treatment of bacterial infections. Penicillin proved to be effective in
treating bacterial infections during World War II, yet it was not long before resistance to the
antibiotic emerged. In fact, penicillin-resistant strains were already identified in the 1940s.13 Since
then, antibiotic research and development has come a long way, yet widespread antibiotic
resistance is still a problem with no lasting solution even today. Moreover, multiple drug resistant
(MDR) strains have been identified, which pose a considerable threat as they create severe clinical
problems. Years of increased and widespread overuse of antibiotics are eliminating the more
susceptible strains, while selecting for the more tolerant ones. Hence, those that survive are the
antibiotic resistant ones. When considering how to treat infections caused by strains with multidrug resistance, multiple drugs may be used.14
Antibiotics are able to kill bacteria by targeting either their ability to reproduce, in which
case they are called bacteriostatic, or their ability to produce necessary enzymes for their various
functions and thus killing them, in which case they are called bactericidal. There are some that are
considered broad spectrum antibiotics, more commonly used by doctors due to their effectiveness
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against a wider range of bacteria. Below some of the different types of antibiotics relevant to my
research are presented.

Aminoglycosides
Aminoglycosides are bactericidal and work by preventing bacteria to produce proteins that
are essential for their function. Their basic structure consists of several aminated sugars bonded to
a dibasic cyclitol (aminocyclitol) through a glycosidic bond.15 For many clinically relevant
aminoglycosides that aminocyclitol is a 2-deoxystreptamnine (2-DOS) ring and is a characteristic
structural feature.16, 17 Amino and hydroxyl substitutions to the core alter the molecule’s mode of
action

18

. Aminoglycosides act by binding to the ribosomes’ small ribosomal unit in the cell’s

cytosol and impairing the bacteria’s ability to produce proteins.19 This causes misreadings or
inhibition of translocation and thus interferes with the process of translation.17 The mistranslations
result in a misfolded protein that, when inside the cell envelope, increases drug uptake and, in
combination with the increased ribosome binding lead to cell death.20 Kanamycin belongs to this
category.
Tetracycline and its derivatives bind the 16S rRNA component of the 30S ribosome subunit
and block access of aminoacyl tRNAs to the ribosome. They do not cause mistranslation but
instead limit the bacteria to a stationary state of growth.20, 21 An interesting note is that even
bacteriostatic antibiotics can cause cell death depending on the bacterial species or the treatment
type. This has been found to be due to the sequence differences in the ribosomal proteins and
RNAs.22 When used in high concentrations, it has been found that they are capable of binding to
ribosomal units of mammalian cells as well, due to their lack of specificity in binding.23
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Streptomycin was the first from this group of antibiotics to be used in 1944 and was derived
from Streptomyces griseus. Waksman and his colleague, Schatz, received the Nobel prize for the
discovery of this antibiotic and its antimicrobial properties against Mycobacterium tuberculosis.
24, 25

It was subsequently produced and applied for treatment in medical cases of tuberculosis.26 In

contrast to penicillin, which is effective against gram-positive bacteria, streptomycin is effective
against a broad range of both gram-negative and gram-positive bacteria.27 Following streptomycin
several other members of this class of antibiotics were isolated and synthesized, including
neomycin, gentamycin, and kanamycin.18
Due to aminoglycosides mode of action, they need to be found in the bacteria cell’s
cytoplasm to be effective. Kanamycin A at physiological pH levels is triply protonated and can
interact with the negatively charged bacterial membrane, increasing its disorder and contributing
to the damaging effects against bacteria 16. Kanamycin and aminoglycosides in general are able to
ultimately reach the cytoplasm of the cell through hydrophilic diffusion.28 Aminoglycosides have
been found to be most effective against gram-negative bacteria instead of gram-positive.29

β-lactams
This class of antibiotics includes penicillin, cephalosporins and carbapenems. A key
structural feature for these is the highly reactive β-lactam ring which contains 3 carbons and 1
nitrogen.30 These antibiotics target the bacteria’s cell wall which is composed of peptidoglycan.
The bacterial cell wall of gram-positive and gram-negative cells differs in composition, with the
former’s consisting of more layers of peptidoglycan, resulting in a thicker cell wall, while the
latter’s less layers, resulting in a thinner cell wall.31, 32 This antibiotic class’s mode of action is by
covalently binding to penicillin binding proteins (PBPs), which are essential for hydrolyzing the
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crosslinking of the peptidoglycan cell wall.30 The cell wall starts to break down, ultimately
resulting in cell wall rupture.32 β-lactams are inhibited by β-lactamases, which are the main mode
of antibiotic resistance against this class of antibiotics. Development of β-lactamase inhibitors to
counteract the action of the β-lactamases has proven to restore the susceptibility to the antibiotic
in some cases and make for a tool with great promise for combating MDR microbes.33, 34
Ampicillin is a β-lactam, penicillin derivative that is active against gram-positive and gramnegative bacteria. Ampicillin is the second antibiotic that is used in my research, as it is
incorporated as a selection marker in the pUC57 plasmid vector being used as a building block for
pKB. It is a broad-spectrum antibiotic and when used in combination to β-lactamase inhibitors, it
has been known to be effective against MDR microbes by restoring their susceptibility to the
antibiotics.34
The spread of genes of ampicillin resistance has revealed some interesting discoveries. The
genes associated with the production of β-lactamase, known as bla genes which are mostly
responsible for ampicillin resistance, have been found to be associated with mobile genetic
elements, such as plasmids, that are capable of being transferred across bacteria.35-38 Interestingly,
in a study performed by Laskey and colleagues, investigating the capability of transfer of plasmid
that carried genes of ampicillin resistance among three different bacterial strains in mice, it was
found that it is possible from the gram negative E. coli to Salmonella as well as a different strain
of E. coli.39

Antibiotic Resistance
The problem of widespread antibiotic resistance is a multi-faceted one, whose effects
have a huge impact on society each year, with antibiotic resistant bacteria infecting more than
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2.8 million people and causing 35,000 deaths annually.40 The emergence of antibiotic resistant
microbes is predicted to have an even greater cost in human lives over the next years, with
estimates predicting that within the next 30 years infections from antibiotic resistant microbes
will cause the death of more than 10 million people annually, exceeding death even from cancer.
40, 41

The strain and financial burden that antibiotic resistant infections put on both the healthcare

system and individuals is great. At the same time, a decrease in innovation in antibiotic drug
development has failed to produce novel antibiotics to keep up with the pace that microbes are
developing resistance to treatments.42, 43 The challenge itself of producing an antimicrobial drug
to which bacteria will not soon develop resistance, large development costs, and low approval
rates have been a great demotivator for large pharmaceutical companies to be part of the
antibiotic production pipeline.44
To combat the issue of antibiotic resistant infections, a first very important step is to
decrease and eliminate the overuse and abuse of antibiotics in healthcare and elsewhere. While
over-prescription of antibiotics and incorrect consumption are a great part of the problem, 80%
of the use of drugs in the United States is in agriculture.45, 46 Antibiotics are used to enhance the
growth of livestock more so than to fight off dangerous diseases, a stark sign of overuse.45, 47, 48 It
has been proven that overuse of antibiotics in agriculture also affects antibiotic resistance in
clinical settings.49
Six pathogens that are notorious for nosocomial infections that are especially hard to treat
due to their high pathogenicity and resistance to multiple drugs, make up the acronym ESKAPE.
These are: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumannii, Pseudomonas aeruginosa, and Enterobacter species.50 These are bacteria that have
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high mortality rates.51 There are multiple ways these pathogens have been able to acquire
antibiotic resistant genes.
Aside from the development of resistance mechanisms to certain drugs, transfer of genes
of antibiotic resistance from one strain to another is achieved through HGT. The various
mechanisms of HGT such as plasmid conjugation, transduction via bacteriophage and
transformation by uptake of naked extracellular DNA, allow for genes to be shared by means
other than vertical transfer from parent to daughter cell.52 Especially in clinical settings, this has
allowed for exchanges between P. putida with the pathogenic P. aeruginosa, the former of which
has been characterized as a gene exchange platform, including for genes of antibiotic resistance,
for the latter.53 Similar is the case for S. epidermis and the pathogenic S. aureus.54 These
examples show how once antibiotic resistance is found in an environment, it is not only possible,
but almost inevitable, for it to transfer between bacterial strains. Moving forward, it is vital that
researchers, medical workers, policymakers, and those working in agriculture, coordinate
towards the common goal of slowing antibiotic resistant infections caused by overuse of
antibiotics in all fields and the development and implementation of new, more effective tools
against them.

Horizontal Gene Transfer
Gene transfer is essential for the spread of antibiotic resistance among different bacterial
strains. This is made possible through the help of mobile elements such as plasmids.55 In contrast
to vertical gene transfer, which is from parent to daughter cells, and achieved through replication
(Figure 1A), HGT is achieved by transduction, carried through with the help of viral vectors, such
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as bacteriophages, transformation and conjugation (Figure 1B). These represent the main
mechanisms of horizontal or lateral gene transfer in bacteria.
Bacterial conjugation is achieved by a pilus or adhesins between the two bacteria that
facilitate the DNA transfer from the donor cell to the recipient.56, 57 This allows for the exchange
of plasmid vectors that carry various genes. The drivers of this exchange may be environmental
pressures. 58 In a study by Laskey and colleagues, it was demonstrated that only when the selective
pressure of the mice being treated with ampicillin was present was there plasmid transfer from the
strain that already was ampicillin resistant to recipient strains in the mice gut. In contrast, when
the mice were not treated with ampicillin, there was no plasmid transfer observed as the only
strains that were able to colonize the mice’s gut were those that already had the plasmid carrying
genes for ampicillin resistance.39
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Figure 1. Mechanisms of gene transfer between bacteria. (A) Vertical gene transfer refers to the
gene transfer from parent cell to daughter cell. Changes in the genetic material occur in the form
of mutations. (B) Horizontal gene transfer refers to gene transfer from a non-vertical gene transfer
from a donor bacterial cell to a recipient cell. Two main forms of gene transfer are transformation,
during which the recipient cell uptakes DNA from the environment after it has been released by
the donor cell, and conjugation, during which donor-cell to recipient-cell contact facilitates transfer
of DNA, usually in the form of a mobile element, such as a plasmid. Figure created using MS
Word.

The exact molecular mechanism of conjugation is complex and requires coordination on
multiple fronts, as elements from the cytoplasm of the cell are not only being transferred outside
the cell, but the bacterial cell is paired to another one. A membrane-associated secretion system is
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employed for the purpose of DNA transfer, known as type IV secretion system (T4SS) (Figure
2).56 As part of this system, DNA mobilization genes are used to mobilize DNA that will be
transferred, while mating pair formation genes code for proteins that will be part of the
macromolecular structure of T4SS. DNA transfer replication genes are responsible for binding to
DNA at the origin of replication (oriT) of the donor cell plasmid and form a structure called a
relaxosome, which itself consists of several proteins. The complex of proteins that are part of the
relaxosome are capable of acting as a helicase by nicking the plasmid to be transferred within the
oriT site and unwinding the DNA in a 5’ to 3’ direction.59, 60
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Figure 2. Schematic of T4SS. The protein complexes that are part of the pilus (VirB2 and VirB5),
the core complex (VirB6-10), the inner membrane platform with the transmembrane domains of
VirB3, VirB6, VirB8 and VirB10, and the ATPases VirB3, VirB6, and coupling protein VirD3.
Created with Biorender.com and MS Word, based on data from the literature 56, 60

Evolutionarily, T4SS has played an important role in contributing to the plasticity of
bacterial genomes and allows them to acquire genes that grant lateral connections between
bacterial lineages. There are multiple types of T4SS, whose variation in aspects such as gene
content and order result in T4SSs with different component modules that are organized into a
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single functional unit.61 It is noteworthy that these systems are capable of transferring both nucleic
acids and, in certain cases, proteins from gram negative and positive bacteria to prokaryotic and
eukaryotic recipient cells.62 Frequencies with which conjugation takes place among bacteria varies
and differences in frequencies may be attributed to various factors. Generally, it has been found
that decreased taxonomic relatedness between donor and recipient bacterial strains leads to
decreased conjugation efficiencies.61, 63, 64 Furthermore, there are differences in T4SS systems in
gram-negative and gram-positive microorganisms. While T4SSs in gram negative organisms have
been well studied and characterized, with the most well studied being that of Agrobacterium
tumefaciens, gram positive ones are less characterized. From the knowledge we have on grampositive conjugation so far, we know that it works better with self-transmissible or conjugative
plasmids.65 These are plasmids that incorporate sequences for their MPFs and thus are mobilizable
on their own.
However, donor-recipient compatibility is not the only contributing factor to conjugation
efficiencies. In experiments performed on mice, to investigate gene transfer through conjugation
in the gut microbiota plasmids with different characteristics interfering with conjugation were
used. Their conjugation efficiencies were measured using probed cells inside the gut microbiota.
From this study, only one plasmid was able to be transferred to all probed cells, while the others
has low or no transformation efficiencies.66
Lastly, it is known that T4SS contributes to the pathogenicity of bacteria, either by allowing
them to uptake genes that increase their pathogenicity, or as it was more recently shown to secrete
toxin effectors into other bacteria resulting in their destruction.67 It was found that the plant
pathogen Xanthomonas citri
maltophilia

70

68, 69

and human opportunistic pathogen Strenotrophomonas

are capable of killing rival bacteria by secreting toxin effectors through T4SS 71.
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In my thesis research, environmentally and clinically relevant strains were selected in order
to investigate their interactions and HGT capabilities with those of the genetically engineered
cyanobacteria, altered with the aim of producing biofuel. By investigating the presence of designer
genes that were originally transformed into cyanobacteria in bacteria that they were in co-culture
with, we are able to understand where HGT has occurred. We do this by employing genes
conferring antibiotic resistance, which grant the bacteria that have uptaken them the ability to grow
on media supplemented with antibiotics –kanamycin (40 μg/mL) or ampicillin (100 μg/mL).

Bacterial Strains
Thermosynechoccus Elongatus BP1
The genome of this bacteria was sequenced entirely in 2002 by Yasukazu et. al and it was
found to be 2,593,857 base pairs long with no plasmid detected. It is a thermophilic bacterium that
ideally lives in temperatures ranging from 45˚C to 55˚C and was originally isolated from hot
springs in Japan.72 Under the microscope it appears rod-shaped. As a photosynthetic
microorganism, T. elongatus BP1 has the ability to uptake inorganic carbon from the atmosphere,
yet it has also been found to be capable of assimilating organic carbon that was supplemented in
the media.73 The doubling time of this bacterium is 7-12 hours depending on how close to its ideal
temperature it is being grown.74, 75

Escherichia coli
E. coli is a very well characterized bacterium, whose early success in first cloning
experiments have made it the bacterium of choice for molecular cloning and continues to be used
even today. It is a gram-negative, rod shaped bacterium, with a duplication time of
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approximately 20 minutes. There are both pathogenic and non-pathogenic E. coli strains. Less
than 1% of human gut bacteria constitute of E. coli or E. coli related bacteria, as they maintain a
symbiotic relationship with the host organism by producing vitamin K12 as well as preventing
gut colonization by pathogenic bacteria.76, 77
There are hundreds of E. coli strains currently known and being used in research
laboratories. They are all derivatives of two main wildtype strains the K12 and B strain.78 The
derivatives of these strains that are commonly used in laboratory settings, such as the DH5α
strain, have undergone various types of genetic modifications. The DH5α strain specifically has
been modified to be negative for recA and endA genes. The endA gene codes for endonuclease I,
which degrades double-stranded DNA, thus affecting the stability of the produced pDNA, while
recA catalyzes DNA strand exchange reactions in ATP-dependent homologous recombination.79
A mutation in its lac operon, lacZΔM15, makes it possible to perform blue-white screening of E.
coli DH5α colonies to select for transformants when using plasmids such as pUC plasmids
containing the lacZα sequence.80, 81 These modifications make E. coli DH5α ideal for use in
cloning methods and plasmid amplification.

Pseudomonas putida
Pseudomonas putida KT2440 is a gram-negative type of bacteria that is commonly found
in soil and water. It is an opportunistic pathogen in nosocomial settings but otherwise is rarely the
cause of diseases, a characteristic that makes it safe for use in industry for synthetic processes,
along with its metabolic robustness.82, 83 P. putida has the ability to degrade aromatic compounds
found in its environment and can grow on such substrates, such as toluene and xylenes.84 For this
reason, is also used in chemical synthetic processes, with rapid growth and high biomass yield.85
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Specifically, P. putida KT2440 has been found to have high tolerance to heavy metals and
metalloids, whose abundance is increased in the rhizosphere, which make this strain appealing for
potential industry application.86 This has been characterized as an evolutionary trait that allows it
to reside in depths of the soil where roots are found.
P. putida KT2440 is rarely identified as the cause of disease in cases not associated with
an immunocompromised state, with the first such case of bacteremia reported in 2013.82 P. putida’s
relative, Pseudomonas aeruginosa is the pathogen lying behind most nosocomial infections of this
strain.87 It is part of the group of pathogens collectively known and referred to as ESKAPE
pathogens, which are commonly found in clinically acquired infections.88 In certain cases of
hospital acquired infections, P. putida bacteria were found along with P. aeruginosa. Genetic
studies of these bacteria lead to the conclusion that P. putida served as an exchange platform of
antibiotic resistance genes for P. aeruginosa.53 This makes it especially dangerous for spread of
antibiotic resistance in strains in hospitals and communities. In addition to their antibiotic
resistance, both P. aeruginosa 89 and P. putida 83 are able to produce biofilm which enhances their
ability to adhere on medical devices by forming clusters along with a self-produced adhesive
matrix which includes polysaccharides, proteins and DNA.90 In hospital settings, biofilm
formation allows these bacteria to contaminate surfaces and medical devices as well as develop
antibiotic resistance.91

Research Aims
The overall aim of this thesis is to provide further insight into the bio-risk that genetically
modified organisms (GMOs) pose for the transfer and spread of foreign genes into the
environments that they are introduced. An assessment is conducted of GE cyanobacteria’s
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capabilities to transfer genes of antibiotic resistance to bacterial strains they may encounter in their
environment should they be found outside of contained laboratory conditions. The implications of
this research are not only important for potential biofuel applications involving cyanobacteria, but
for applications of GMOs in general. As we develop more sophisticated tools to manipulate
genomes of microorganisms, their interaction with their environment and other bacteria is of
particular interest from a biosafety perspective.
In aim one, the plasmid carrying the designer genes for biofuel production and
antibiotic resistance to ampicillin and kanamycin, is introduced to the cyanobacteria, T.
elongatus BP1 and three gram-negative strains to assess their capacity of carrying the
plasmid. The three gram-negative bacterial strains transformed and studied along with the T.
elongatus BP1 cyanobacteria are: E. coli DH5α, E. coli K12, and P. putida. The success of the
transformation and the ability of a strain to carry the plasmid is assessed from the ability of the
transformants to grow on media supplemented with antibiotic, as antibiotic resistant genes were
included in the plasmid construct as selective markers. The strains were selected based on different
criteria. E. coli DH5α is a commonly used laboratory strain that is often used for molecular cloning
procedures and thus studying it alongside the GE cyanobacteria would provide us information
about the horizontal gene transfer process with recipient cells optimized for uptake of foreign
DNA. E. coli K12 is the parent strain to E. coli DH5α and has not undergone genetic modifications
to prime it for such processes, thus it is more of a wild-type E. coli strain. Lastly, P. putida is a
soil bacterium that could be found in the same environment as the cyanobacteria should the latter
escape laboratory containment and is also a relative of the pathogenic P. aeruginosa that is
notorious for causing infections in clinical settings.
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In the second aim we study the ability of the cyanobacteria to transfer plasmid
encoded genes conferring antibiotic resistance to two model E. coli strains, E. coli K12 and
E. coli DH5α, while in the third aim we study the capability of HGT from the cyanobacteria
to P. putida KT2440. These two aims were designed to provide insight into the mechanisms of
HGT and the fate of genes conferring antibiotic resistance between the model cyanobacteria and
the three selected bacterial strains. By demonstrating that HGT is possible from GE cyanobacteria
to these strains that may interact with outside of laboratory containment, it is possible to formulate
containment strategies for large scale applications of GE cyanobacteria for biofuel production to
effect escape and understand the ramifications should this occur.

Experimental Methodology
The schematic in Figure 3 portrays the combination and overlap of biochemistry,
genetics, microbiology, and bioinformatics techniques used to develop my experimental strategy
and to conduct the HGT experiments. Once the constructed plasmid carrying genes aimed at
biofuel production is transformed into cyanobacteria, the ability of it to be transferred to other
types is assessed by growing them in co-culture with the GE cyanobacteria. The cells are then
plated on selective media supplemented with antibiotics, to see if they have gained tolerance to
it. If they have not, we may have a viable biofuel source safe to the environment and humans.
However, if the bacteria gain antibiotic tolerance, they are a biohazard and containment methods
for future applications should be proposed.
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Figure 3. Graphical representation of the HGT experimental strategy for biohazard assessment of
GE cyanobacteria. It involved transforming the designer pUC-57 based plasmid vector into T.
elongatus BP1. Co-cultures of GE T. elongatus BP1 with wildtype E. coli K12, E. coli DH5α, and
P. putida were set up, and after plating on selective media, bacterial colonies were screened for
presence of the designer plasmid genes.

Bioinformatics
The pKB DNA construct was designed using DNAstar bioinformatics software tools and
synthesized in collaboration with GenScript.com. The pKB DNA construct comprises PnirA nirA promoter, KDC - keto-acid-decarboxylase, BDH - butanol dehydrogenase, PslpA - slpA
promoter, KanR – kanamycin resistance gene, and Term-rubisco terminator. Up (RSI) and
downstream (RSII) of the cassette are homologous recombination site sequences. Primers for
PCR amplifications of certain genes of the plasmid and genes of the bacterial strains’ genome
were designed using CLC Genomics Workbench v.12 software (Qiagen). Primers for
distinguishing among the selected bacterial strains during experiments (Appendix A) and
sequencing data acquired from the HGT experiments were also designed using this software.
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Polymerase Chain Reaction
Polymerase chain reaction (PCR) is a common molecular biology technique that has
recently gained much attention due to real time PCR (RT-PCR) being the method of choice for
diagnosing patients with COVID-19.92 By creating multiple copies of a target DNA template, we
are able to amplify that DNA fragment and detect it using gel electrophoresis. This is a technique
based on the separation of DNA fragments by size within an agarose gel using an electric field.
Each DNA fragment produced by PCR has a specific size which can then be detected on the gel
and measured using a DNA ladder.

Electroporation
To introduce the plasmid DNA into the wildtype cyanobacteria and assess the bacteria’s ability
to carry the plasmid, the pKB plasmid was transformed into these microorganisms using
electroporation. The bacteria are inserted into a cuvette that is placed in to the electroporator
(BIO-RAD, GenePulser Xcell). Optimized parameters for voltage, capacitance, and resistance
for each bacterial strain are programmed into the electroporator to produce the appropriate pulse.
The pulse allows for the plasmid to be inserted in the bacterial cells through pores formed as the
pulse is discharged in the suspension where the cells and plasmid are present.93

Cell cultures
Co-cultures of the GE T. elongatus BP1 cyanobacteria along with E. coli K12, E. coli
DH5α, and P. putida KT2440 were grown and cells were plated on selective media to determine
which had taken up genes conferring antibiotic resistance. Monocultures of the different species
are used for the appropriate control cultures.
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Significance of Research
The need for green energy and the focus on GMOs creates both possibilities and
problems. The latter is the concern over the unintended consequences of using GMOs. This is
especially crucial as the emergence of antibiotic resistant strains is a major health threat that we
are currently facing. Widespread antibiotic resistance among strains that are commonly found in
clinical settings are the cause of more than 2.8 million antibiotic resistant infections and more
than 35,000 deaths in the US, as reported by the CDC 2019 report.94 The significance of this
work lies in both the value of assessing the biohazard that GE cyanobacteria may pose when
considered for biofuel production and the transfer capabilities of genes of antibiotic resistance to
E. coli K12, E. coli DH5α and P. putida KT2440.
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CHAPTER II
MATERIALS AND METHODS

Strains and Culture Conditions
T. elongatus BP1 is a photoautotrophic, thermophilic strain grown at 45˚C under constant
light conditions under fluorescent lamps. The media used for the cyanobacteria in these studies
were BG-11 and BG-110SA, the latter being a modified version of the former, as 4mM of
(NH4)2SO4 is the nitrogen source instead of KNO3. This has been used as such by Thu et al. in
studies using the same type of cyanobacterial transformants 95 and has been described
previously.96 Additionally, the BG-110SA growth medium for the T. elongatus BP1
transformants was supplemented with kanamycin (40 μg/mL). E. coli K12, E. coli DH5α, and P.
putida KT2440 were grown in Luria Bertani (LB) medium at 37˚C. Transformed E. coli K12 and
E. coli DH5α were grown in LB medium supplemented with either kanamycin (40 μg/mL) or
ampicillin (100 μL/mL). P. putida 2440 transformants were grown in LB medium with
kanamycin (40 μg/mL).

Plasmids
pKB plasmid
The plasmid that was used in this research has been used to demonstrate HGT from
transformed T. elongatus BP1 to E. coli DH5α.95 It is based on the pUC-57 plasmid vector,
which carries genes of ampicillin resistance, and a pmb1 origin of replication (Figure 4). The
designer genes, which aim to confer the ability to the cyanobacteria to produce butanol, keto-acid
decarboxylase and butanol dehydrogenase, are found between two recombination sites, RSI and
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RSII. They are preceded by an inducible promoter (nirA), which is induced by nitrate presence in
the media 97, 98 and repressed by ammonium.99, 100 The KanR gene conferring kanamycin
resistance is preceded by two continuous promoters, the promoter for the cpc gene from T.
elongatus BP1 and the promoter for the slpA gene of Thermus thermophilus. Finally, the cassette
contains a rubisco terminator. The total size of pKB is 9,007bp.

Figure 4. Schematic of the pKB plasmid design. The plasmid was constructed to carry the
annotated set of genes: PnirA - nirA promoter, KDC - keto-acid-decarboxylase, BDH - butanol
dehydrogenase, PslpA - slpA promoter, KanR – kanamycin resistance gene, and Term-rubisco
terminator. Up (RSI) and downstream (RSII) of the cassette are homologous recombination site
sequences aimed at guiding the integration of the cassette, into the cyanobacteria’s genome. The
origin of replication, oriT, and the ampicillin resistance gene, AmpR, are part of the pUC57
vector used to construct the cassette. Adapted from Nguyen et. al.95
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pUC19
A minimal plasmid, without the cassette carrying the alcohol producing genes, was
transformed into the E. coli K12 and E. coli DH5a for comparison of the transformation results
with those of electroporation with the pKB plasmid. pUC19 is related to pUC57, which is used
for the construction of pKB, and contains the same ampicillin resistance gene and origin of
replication.101-104 Its size is 2,686 bp. The pMB1 origin of replication ensures high copy
numbers.105 pUC19 also contains a fragment from the N-terminal of the β-galactosidase gene,
that is part of the well-characterized lac operon, and offers another selection system for pUC19
transformants containing a lacZΔM15 mutation, such as E. coli DH5α Top10.80

Genetic Transformation of pKB into T. elongatus BP1
Wild-type T. elongatus BP1 cells were grown in liquid BG-110SA medium to reach
OD730=20.0. They were pelleted down by centrifugation and resuspended in 400 μL of water.
1μg of the pKB plasmid was added to the cell suspension. Electroporation was done at 5 kV/cm
in a 2 mm cuvette using BioRad PowerPac Basic. A single pulse was provided for each
transformation. Immediately after, the cells were transferred into flasks with 5mL of BG-110SA
medium pre-warmed at 45˚C. The cells were then incubated overnight at 45˚C, under constant
light conditions prior to being spread on agar BG-110SA medium supplemented with kanamycin
(40 μg/mL). After 10-14 days of incubation at 45˚C and under constant light conditions, colonies
of the transformed cells carrying the pKB with the kanamycin-resistance genes used as a
selective marker appeared on the agar plates containing antibiotic. The colonies were streaked
onto new plates and liquid cultures with BG-110SA medium with kanamycin (40 μg/mL) were
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prepared as well, thus establishing a line of GE cyanobacteria to be used for the HGT
experiments.

Verification of Cassette in T. elongatus BP1
Plasmid extraction was performed on the green colonies that grew on the BG-110SA
plates with kanamycin (40μg/mL). PCR was performed to verify the presence of the pKB
plasmid in the transformed cells. Two primers, Amp_fwd
(TTACCAATGCTTAATCAGTGAGGCAC) and bdh0318_rev
(CCTCCATTTCCTTTGCACCCT) were used, which were used to verify the plasmid as per
Nguyen et al. with an expected band size of 4.5 kb.95

Horizontal Gene Transfer Experiments
Transformed T. elongatus BP1 cyanobacteria were grown in BG-110SA medium
supplemented with kanamycin (40 μg/mL), at 45˚C, under constant illumination conditions,
while their concentration was monitored by cell counting using a hemocytometer and an upright
microscope (OLYMPUS LS). E. coli K12, E. coli DH5α, and P. putida K2440 overnight cultures
were grown at 37˚C. Transformed T. elongatus BP1 cells were pelleted down by centrifugation,
the supernatant was discarded, and the cells were suspended in fresh BG110SA medium without
kanamycin to a final concentration of 107 cells/mL. 15 mL of the cyanobacterial suspension were
then mixed with 15 mL of cells from each of the other strains, E. coli K12, E. coli DH5α, and P.
putida KT2440 respectively, each at a concentration of 107 cells/mL to create the co-cultures.
The resulting liquid co-cultures contained 15mL of LB medium and 15mL of BG-110SA for a
total of 30mL. These co-cultures were incubated in a shaking incubator at 37˚C, under constant
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light conditions provided by daylight fluorescent lamps. The controls for this experimental set-up
were 30 mL cultures containing 15 mL of LB medium and 15 mL of BG-110SA medium with
only one bacterial strain. Experiments were performed in triplicates.

Control Studies
Testing the Ability of E. coli DH5α, E. coli K12, and P. putida to Uptake DNA from the Media
The ability of E. coli K12, E. coli DH5α, and P. putida KT2440 to uptake the pKB
plasmid from their media was evaluated by setting up 30 mL liquid cultures containing 1:1 LB to
BG-110SA ratio. Cell suspensions of E. coli K12, E. coli DH5α, and P. putida KT2440 at a
concentration of 107 cells/mL each, in addition to the 1μg of the plasmid, were added to the 30
mL liquid media. The cultures were incubated under constant light conditions and at 37˚C for 2
days before being plated on selective media. This was a critical control experiment aimed to
demonstrate that any HGT observed from co-cultures of the bacteria was not an artifact of the
DNA uptake from the supernatant.

Genetic Transformation of pKB into E. coli DH5α, E. coli K12, and P. putida KT2440
To assess the ability of the different bacterial strains to carry the plasmid, the plasmid was
initially transformed directly into the cells. Prior to the transformation, the cells were made
competent using the following protocol. Cells from 10mL volumes of overnight cultures at a
concentration of 109 cells/mL as determined by cell counting were centrifuged down to a pellet.
The supernatant was discarded. Of particular importance was to discard the supernatant in its
entirety even at the expense of a few cells, so that no arc would be detected during the pulsing step
of the electroporation due to the salts of the culture growth medium. A mixture of 10% glycerol
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was prepared using filtered glycerol and Millipore water. For each of the different types of bacteria,
3 washes with 2mL, 1mL and 0.5mL of cold glycerol were performed respectively, centrifuging
the cells for 3 minutes at maximum speed for each wash. During the washes, the cells were placed
on ice and the temperature of the centrifuge was kept at 4℃.

Figure 5. Transformation via electroporation. (A) Cells were made competent and suspended in
10% glycerol. (B) The cell and plasmid suspension were placed inside a pre-chilled 2mm cuvette.
(C) The electroporation parameters were set on the electroporator. (D) The time constant was
recorded for each electroporation.

Figure 5 shows snapshots of the process leading up to the pulsing of the bacteria for
transformation of the plasmids. A 40-100μL volume of the electrocompetent cells was inserted in
a microcentrifuge tube along with 0.5-1.0 μg of plasmid DNA and incubated on ice for 1minute.
Plasmid DNA and cell mixture were transferred to pre-chilled 2mm cuvettes (Figure 5B) and were
placed in the electroporation chamber of a Bio-Rad Gene Pulser Xcell microbial system that was
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used for electroporation of the cells, following exponential decay protocols (Figure 5D). The cells
were pulsed according to the parameters that were provided for each bacterial strain by the
electroporator manufacturer, however, they were optimized for our cells to yield better
transformation efficiencies. These parameters are summarized in Table 1. The cells were pulsed
once and immediately transferred to a microcentrifuge tube with 1 mL of room temperature LB
medium. The electroporated cells were incubated for 1 hr at 37℃, under shaking conditions of 150
rpm, before being plated on selective media. Transformed E. coli K12 and E. coli DH5α were
plated on LB agar, LB with Kanamycin (40 μg/mL) and LB with Ampicillin (100 μg/mL), while
P. putida KT2440 was plated on LB and LB with Kanamycin only, as it is naturally resistant to
the Ampicillin. The plates were incubated at 37˚C for the next 4 days. Colonies that were able to
grow on antibiotic following electroporation typically appeared after 2-3 days and were then
screened for the presence of transgenes from the plasmid using colony PCR. Experiments were
performed in triplicates.

Table 1. Summary of Electroporation Conditions for the Bacterial Strains
Bacterial Strain

Cuvette (mm)

Voltage
(V)

Capacitance
(μF)

Resistance
(Ω)

T. elongatus BP1

2

1000

25

100

E. coli K12

2

2500

25

200

E. coli DH5α

2

2500

25

200

P. putida KT2440

2

1000

25

200
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PCR Analysis and DNA Sequencing
To prepare the DNA for the colony PCR, with the tip of a cell spreader cells in a colony
from the plate were put into 30 μL of Millipore water and incubated for 5 min. at 95℃. The mixture
was then centrifuged for 3 minutes at maximum speed to collect cell debris on the bottom of the
tube while keeping the DNA in the supernatant. For colony PCR, 2 μL of DNA template were used
from these prepared samples. Apart from that, for the PCR mixtures for each of the samples, 10
μL of Phusion high fidelity PCR master mix (Thermo Fisher Scientific) were used, along with 0.5
μM of forward and reverse primers respectively, all of which add up to a total of 20μL of reaction
mixture.
The transfer of the genes from the GE cyanobacteria to the various bacterial strains was
confirmed with the detection of the foreign genes in bacteria from the co-culture with the
transformed T. elongatus BP1 using PCR and DNA sequencing. Amplification was achieved with
the

primers

cpcPKan_fwd

(TAATAGGCGTTTCCCTTCGTTGCC)

to

KanN_rev

(CAAAATGGTATGCGTTTTGACACATCC). Sequencing of the PCR product of the amplified
1kb kanamycin resistance gene was done by the Eastern Virginia Medical School Molecular Core.
Alignments of the sequenced region were made using CLC Genomics Workbench v.12 (Qiagen)
software.
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CHAPTER III
RESULTS AND DISCUSSION

Transformation Experiments
Transformation of T. Elongatus BP1
Transformation of T. elongatus BP1 resulted in cyanobacteria transformants with the
ability to express kanamycin resistance and grow on media supplemented with kanamycin (40
μg/mL) (Figure 6A). Colonies were obtained from transformation via electroporation after 14
days and were restreaked and grown in liquid media supplemented with kanamycin (40 μg/ mL)
(Figure 6B). Amplifying a DNA region from plasmid extraction of the transformed
cyanobacteria both part of the pUC57 vector and the cassette containing the genes aimed at the
production of biofuel using primers Amp_fwd (TTACCAATGCTTAATCAGTGAGGCAC) and
bdh038_rev (CCTCCATTTCCTTTGCACCCT), produced the results of Figure 6C. pKB is
detected in sample 3 at 4.5 kb, at the same size as the positive control (Figure 6C). Primers
cpcp_Kan_fwd (TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev
(CAAAATGGTATGCGTTTTGACACATCC) were used to amplify the region containing the
kanamycin resistance gene. The gene was detected at the expected band size of 1kb in Figure
6D) for the plasmid “P”.
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Figure 6. Transformation of pKB into T. elongatus BP1. (A) Colony growth on BG-110SA agar
plate after 7 days of incubation under constant light conditions at 45˚C. (B) Cells were grown in
liquid culture BG-110SA media supplemented with kanamycin 40 μg/mL. PCR on DNA from
plasmid extraction from transformed T. elongatus BP1 using primers (C) cpcp_Kan_fwd and
KanN_rev. and D. bdh_fwd and amp_rev. In panels C. and D., “M” denotes the molecular
weight marker. pKB was used as the positive control, denoted with “+”, while WT T. elongatus
BP1 were used as the negative control, denoted with “- “. Plasmid extracted from transformed T.
elongatus BP1 is denoted with “P”.
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Transformation of E. coli K12
The results of the transformation of E. coli K12 are shown in figure 3. Following plating
of the electroporated cells, no colonies were observed after 3 days of incubation on the plates
containing antibiotic. Transformation was repeated 4 times, altering electroporation parameters
with the same results. This was perplexing as, in contrast, the E. coli DH5α had growth of
individual colonies on ampicillin, as is depicted in Figure 5A. Suspecting that the reason for the
unsuccessful transformation of E. coli K12, the true wildtype E. coli strain is the size of the plasmid
in a bacterial strain which, unlike E. coli DH5α is not primed for cloning procedures, a different
plasmid was transformed into E. coli K12. pUC19 is a minimal plasmid, it contains no cassette
with genes of antibiotic resistance, but contains the same ampicillin resistance gene as pUC57 that
was used for the construction of pKB and the same pMB1 origin of replication (Figure 7B).101-103
Therefore, by transforming E. coli K12 with pUC19, we were able to see that while pKB was not
transformed and expressed in E. coli K12, a plasmid with similar characteristics but smaller in
size, 2,686bp versus 9,007bp, was able to be successfully transformed into the bacteria. The plates
where electroporated cells were plated and incubated were covered with growth (Figure 7C).
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Figure 7. Transformation of E. coli K12. (A) The agar plates onto which pulsed E. coli K12 cells
were plated on after electroporation with pKB. Check marks indicate presence of growth, while
x’s indicate no growth on the plate. (B) Schematic of the pUC19 plasmid vector. (C) The agar
plates onto which pulsed E. coli K12 cells were plated after electroporation with pUC19 and 1 day
incubation at 37˚C.
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Transformation of E. coli DH5α
There were 16 colony forming units (CFUs) that were counted on the ampicillin plates
where pulsed E. coli DH5α were plated (Figure 8A). They were screened with primers
pmb1_fwd (CCCCCCTGACGAGCATCAC) and AmpR_rev
(ATGAGTATTCAACATTTCCGTGTCG).

Figure 8. Τransformation of pKB into E. coli DH5α. (A) The plates onto which pulsed E. coli
DH5α was plated on. (B) PCR amplifying the region of the plasmid containing the origin of
replication and the gene conferring ampicillin resistance. The band matches the expected size of
1.6 kb. The lanes are denoted by: M (molecular weight marker), + (positive control), - (negative
control), lanes 1-4 (DNA sample from transformed E. coli DH5α colonies.

36

This difference between the two strains is intriguing particularly because of the close
relation between these two strains. Since the cells on the LB plate had grown to confluency after
one day of incubation of the plates, the parameters chosen for electroporation of the bacteria were
not lethal to them, otherwise there would be no growth observed. Having excluded the possibility
that the voltage with which the bacteria were pulsed could have been too high and thus detrimental
to them, other possible explanations are explored for why the E. coli K12 were unsuccessful in
taking up the plasmid and expressing the genes that would allow them to grow on either agar plates
with ampicillin or agar plates with kanamycin, when the same parameters were used for the E. coli
DH5α and were successful in producing transformants. When considering the differences between
the two strains, it is notable that DH5α is a K12 derivative whose mutations have been designed
to give it an advantage in cloning procedures. With recA and endA mutations, E. coli DH5α is
designed for maximum transformation efficiency as these mutations grant the bacteria the ability
to uptake foreign DNA without making alterations to it that would affect its expression. Given the
size of the plasmids used in these transformation experiments which are over 10kb, it is possible
that E. coli K12 enzymes prevent the expression of the genes present in the plasmid, thus not
allowing for kanamycin or ampicillin resistance. The recA protein participates in DNA repair and
recombination.106 Bacterial strains that lack the endA1 mutation could destabilize any vector
inserts that they are transformed with by general recombination taking place in the host.107 EndA
codes for endonuclease I which cuts pure plasmid DNA.108 Thus, absence of mutations on these
genes, allows for DNA degradation.
What is more, as counted with the cell counter plugin of ImageJ,109 there were 16 CFUs of
E. coli DH5α present on the plates that the transformants were plated on in this study. 150 μl of
culture were plated on each agar plate. Given that the plasmid was extracted from E. coli DH5α to
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begin with, the low amount of E. coli DH5α transformants obtained is less likely due to the strain’s
inability to carry or express the plasmid. But rather the low efficiency of transformation obtained
by the protocol followed to make the cells competent, which involved using washes of 10%
glycerol while keeping the cells on ice. Either of these explanations or a combination of both could
account for the differences in the results we see for the transformation with electroporation of E.
coli K12 and E. coli DH5α.

Transformation of P. putida KT2440
It is known that P. putida KT2440 is capable of growing on ampicillin prior to
undergoing transformation and for this reason the plating of this strain on selective media was
done on agar with kanamycin. The results are shown in Figure 5. 91 CFUs were counted. Both
the verification of the kanamycin resistance genes and the part of the vector containing the origin
of replication and the ampicillin resistance were achieved with PCR using primers
cpcp_Kan_fwd (TAATAGGCGTTTCCCTTCGTTGCC)with Kan_rev
(CAAAATGGTATGCGTTTTGACACATCC), with a band size for all of the colonies screened
at the expected size of 0.8kb and primers pmb1_fwd (CCCCCCTGACGAGCATCAC)with
AmpR_rev (ATGAGTATTCAACATTTCCGTGTCG) with a band size corresponding to the
expected size of 1.6 kb for three of the five samples screened, as seen in Figure 5.
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Figure 9. Transformation of P. putida KT 2440. (A) Colonies were detected on the plates with
kanamycin where P. putida was plated. Select clusters are circled to indicate their positions in
various locations. The cells on the LB plate grew to 100% confluency. (B) Colony PCR amplifying
the region of the plasmid containing the origin of replication, using the primers pmb1_fwd and
AmpR_rev. The lanes in (B) and (C) are denoted by: M (molecular weight marker), + (positive
control, the pKB plasmid), - (negative control, non-transformed P. putida), lanes 1-5 (DNA sample
from transformed P. putida KT2440 colonies). (C) Colony PCR amplifying the region of the
plasmid containing the kanamycin resistance genes, using primers cpcp_Kan_fwd and Kan_rev.
The DNA sample from them that was used is from the same colonies that were screened in the
PCR in (B).
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Together with the results of electroporating E. coli K12, E. coli DH5α, it is concluded that
these bacterial strains are capable of carrying and replicating the pKB plasmid when transformed
directly into them using electroporation. The low transformation rates are most likely due to the
glycerol protocol followed to make the cells competent, as well as the size of the plasmid. To
confirm the former, the pKB plasmid was transformed into competent E. coli Top10 cells. To
confirm the latter, a control pUC 19 plasmid, with the same origin of replication as the pKB were
transformed into the E. coli K12 and E. coli DH5α cells. pUC19 contains genes of ampicillin
resistance so transformants of E. coli K12 and E. coli DH5α were able to grow on ampicillin plates.

HGT Experiments
The flask setup for the HGT experiments is shown in Figure 7. Flasks with only one type
of bacterial strain are used as controls for each type of bacteria used. Co-cultures of the
transformed cyanobacteria along with each of the E. coli K12, E. coli DH5α, and the P. putida
KT2440 were also set up. All flasks contained a 1:1 ratio of LB to BG-110SA medium that added
up to a total of 30mL. Over the progression of the two days that these cultures were incubated at
37˚C and shaking, they were monitored, and cell counting was done.
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Figure 10. HGT experiments in liquid media. Flasks containing control monocultures, and cocultures with both the cyanobacteria and each of other bacteria (E. coli K12, E. coli DH5α, and
P. putida KT2440) strained were monitored and plated over the course of two days. (A)
Monoculture of GE T. elongatus BP1. (B) Monoculture of E. coli K12. (C) Co-culture of GE T.
elongatus BP1 and E. coli K12. (D) Monoculture of E. coli DH5α E. Co-culture of GE T.
elongatus BP1 and E. coli DH5α. (F) Monoculture of P. putida KT2440 G. Co-culture of GE T.
elongatus BP1 and P. putida KT2440.

41

It is observed that after day one the mono-culture and co-culture flasks containing E. coli
K12, E. coli DH5α and the P. putida KT2440 monoculture obtain a cloudy appearance, and
indication of bacterial cell growth. The mono-culture of GE T. elongatus BP1 and co-culture of
the cyanobacteria with P. putida remain clear. The appearance of the cultures in the flasks is
interesting to consider in correlation with cell counting data (Figure 11) that reveal that in the
cloudier co-culture flasks there are more E. coli K12 (Figure 11A) and DH5α (Figure 11B)
bacteria than the cyanobacteria. Conversely, in the cases when the co-cultures appear mostly
clear, such as the P. putida and transformed BP1 co-culture in Figure 10G, cell counting revealed
low P. putida KT2440 growth (Figure 11C).
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Figure 11. Bacteria growth curves for HGT experiments. Control monocultures of each cell type
(orange), along with GE T. elongatus BP1 from monocultures (red) and co-cultures (yellow) are
shown, while in blue is (A) Growth of E. coli K12 cells from co-cultures, (B) Growth of E. coli
DH5α cells from co-cultures and (C) Growth of P. putida KT2440 cells from co-cultures.
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Figure 12. HGT experiments on plates using selective media. The check marks on the top right
of each plate indicate that there was growth on the plate after 2 days incubation at 37 ˚C (with
the exception of the BG-110-SA plates that took 7-10 days to present with growth) while the x’s
indicate that there was not growth on the plate. Growth of E. coli K12, the co-culture with
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Figure 12 (Continued).
cyanobacteria and E. coli K12, E. coli DH5α, and the co-culture with cyanobacteria and E. coli
DH5α was confluent on the LB plates. A-G labels indicate the culture flask from which cells
were plated on each agar plate. A. Cells from the monoculture of GE T. elongatus BP1. (B) Cells
from monoculture of E. coli K12. (C) Cells from co-culture of GE T. elongatus BP1 and E. coli
K12. (D) Cells from monoculture of E. coli DH5α. (E) Cells from co-culture of GE T. elongatus
BP1 and E. coli DH5α. (F) Cells from monoculture of P. putida KT2440 (G) Cells from coculture of GE T. elongatus BP1 and P. putida KT2440. Asterisks indicate plates are shown
enlarged for more detail in Figure 12 (*) and Figure 13 (**).

From Figure 12 it is observed that there was no growth on the LB agar or LB agar
supplemented with kanamycin (40 μg/mL) or ampicillin (100 μg/mL). The E. coli K12, E. coli
DH5α, and P. putida KT2440 cells from the control flasks with the monocultures were only able
to grow on LB medium, with no antibiotic, whereas E. coli K12 and E. coli DH5α that had been
in co-culture with the transformed T. elongatus BP1 were able to grow on LB agar with
kanamycin (40 μg/mL). There were no colonies of E. coli K12 or E. coli DH5α detected on LB
agar with ampicillin (100 μg/mL) from cells from their respective co-culture flasks with
cyanobacteria.
P. putida KT2440 grown in co-culture with the GE T. elongatus BP1 cyanobacteria did
not grow as well as the P. putida KT2440 control, as indicated by their decreased numbers
(Figure 11C) and the appearance of the co-culture flasks which remained clear even after
incubation of 2 days (Figure 10G). In contrast, the control monoculture of P. putida KT2440
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turned cloudy after day 1 and had increased P. putida growth. Lastly, the growth of P. putida
KT2440 cells from the co-culture with the GE T. elongatus BP1 on the LB plates with no
antibiotic was of individual colonies and not confluent as is the growth demonstrated by cells
from the monoculture of P. putida KT2440 plated on LB agar medium.
In addition, no colonies appeared on the LB plates with kanamycin (40 μg/mL) where
cells from the P. putida KT2440 co-cultures with the cyanobacteria where plated (Figure 12G).
The LB plate where cells from the co-cultures was plated did not present with confluent growth
of P. putida KT2440 but individual pseudomonas colonies after 2 days of incubation. The cells
from the control monoculture of P. putida KT2440 plated on the LB agar medium were
confluent after two days of incubation of the plates at 37˚C. This could be an indication that the
cyanobacteria or their metabolic products are toxic to the P. putida KT2440, resulting in the
latter’s destruction when grown together in co-culture. P. putida KT2440 was not plated on LB
agar with ampicillin because as it is naturally resistant to ampicillin, growth on that antibiotic
would not necessarily be a sign of horizontal gene transfer from the GE cyanobacteria.
The BG-110SA plates required more incubation time to exhibit colony growth of green T.
elongatus colonies and were kept for more than 2 days to ensure the cells were able to grow
(Figure 12). Green cyanobacterial growth appears on the BG-110SA plates from where cells from
transformed T. elongatus BP1 control monoculture and the co-cultures were plated, after 7-10
days of incubation.
Colony PCR that was performed on selected E. coli K12 (Figure 13) and E. coli DH5α
(Figure 14) colonies from the LB plates with kanamycin 40 μg/mL, confirmed the presence of
the genes of kanamycin resistance that were part of the construct transformed into the GE
cyanobacteria that the E. coli K12 and DH5α were in co-culture with. The bands present in lanes
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with DNA from colonies 2, 5, and 6 for E. coli K12 (Figure 13) and 2, 4, 5, and 7 for E. coli
DH5α colonies (Figure 14) are of the expected 1kb band size for the amplified kanamycin
resistance genes. The primers used were cpcP_Kan_fwd
(TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev
(CAAAATGGTATGCGTTTTGACACATCC).
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Figure 13. Confirmation of HGT from GE cyanobacteria to E. coli K12. (A) The LB plates with
kanamycin 40 μg/mL onto which E. coli K12 colonies appeared, as indicated by the check
marks. (B) A closer look at some of the E. coli K12 colonies on LB with kanamycin (40 μg/mL).
(C) Colony PCR on the observed E. coli K12 colonies labeled 1-7, amplifying the kanamycin
resistance gene, produced the expected band at 1kb for samples 2,5, and 6. “M” denotes the
molecular weight marker, “+” indicates the positive control used (pKB), “- ” indicates the
negative control (E. coli K12).
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Figure 14. Confirmation of HGT from GE cyanobacteria to E. coli DH5α. (A) The LB plates
with kanamycin 40 μg/mL onto which cells from co-culture of transformed T. elongatus BP1 and
E. coli DH5α were plated and E. coli DH5α colonies appeared, as indicated by the check marks.
(B) A closer look at some of the observed E. coli DH5α colonies on LB agar medium
supplemented with kanamycin 40 μg/mL. (C) Colony PCR on the observed E. coli DH5α
colonies labeled 1-7, amplifying the kanamycin resistance gene, using primer cpcp_Kan_fwd
(TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev
(CAAAATGGTATGCGTTTTGACACATCC), produced the expected band at 1kb for samples
2,4,5, and 7. “M” denotes the molecular weight marker, “+” is used to indicate the positive
control used, which was the pKB plasmid, and “- ” indicates the negative control used, which
was DNA from E. coli DH5α cells not grown in co-culture with GE cyanobacteria.
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To further validate the presence of the engineered construct in the colonies from the HGT
experiments, overnight cultures from individual E. coli K12 and E. coli DH5α colonies that grew
on LB agar medium supplemented with kanamycin (40 μg/mL) after incubation with the GE T.
elongatus BP1 were grown, and plasmid was extracted from them. PCR was then run to confirm
the presence of the gene conferring kanamycin resistance using primers cpcp_Kan_fwd
(TAATAGGCGTTTCCCTTCGTTGCC) and KanN_rev
(CAAAATGGTATGCGTTTTGACACATCC). The results (Figure 15) show that in 2 out of the
3 samples from plasmid extraction from E. coli K-12 (lanes 1-3), and 3 out of the 3 samples from
plasmid extraction from E. coli DH5α (lanes 4-6) the band of the expected 1kb size was detected.

Figure 15. Confirmation of the presence of the engineered kanamycin resistance genes from
plasmid extraction of E. coli K12 and E. coli DH5α. The expected bands appear at 1kb. “M”
denotes the molecular weight marker; “+” denotes the positive control (PKB); “A-” denotes the
E. coli K12 negative control; “B-” denotes E. coli DH5α negative control; lanes 1-3 contain
DNA sample from plasmid extraction on E. coli K12; lanes 4-6 contain DNA sample from
plasmid extraction on E. coli DH5α.
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These findings demonstrate that E. coli K12 and E. coli DH5α are able to grow in coculture with GE T. elongatus BP1 transformed with the pKB and uptake genes that allow it to be
resistant to kanamycin and grow on LB agar supplemented kanamycin (40 μg/mL). Lastly, proof
of HGT from the GE cyanobacteria to the E. coli K12 and E. coli DH5α strains are the
sequencing results of the kanamycin resistance sequence from the transformed T. elongatus BP1
and the E. coli cells that were able to obtain kanamycin resistance after growing in co-culture
with the GE cyanobacteria. In Figure 15, the trace data from the sequenced kanamycin resistance
gene from the three bacterial strains shows that there is 100% conservation over the region
shown.
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Figure 16. Sequencing of kanamycin resistance gene from transformed T. elongatus BP1 (BP1120) and E. coli K12 and E. coli DH5α. In this figure, which includes trace date from
sequencing, a 270 kb region that is part of the kanamycin resistance gene appears to be
conserved among the three types of strains.
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Control Studies
The capability of each of the bacterial strains used in the horizontal gene transfer
experiments to be naturally transformed by the plasmid in liquid media were assessed. The liquid
cultures in which the bacteria were incubated with the 1μg of plasmid were followed over the
course of 2 days and each day cells from each culture flask were plated on selective media,
containing either kanamycin (40 μg/mL) or ampicillin (100μg/mL), as pictured in Figure 11. P.
putida KT2440 was not plated on LB agar supplemented with ampicillin (100μg/mL) as it is
known that it is tolerant to it. With this setup, the conditions of the HGT experiments were
closely mimicked to control for DNA uptake of these bacterial strains from the supernatant.
The bacteria were incubated at 37˚C, with the same concentration of plasmid that the
cyanobacteria are transformed with. Cells were plated on selective media to assess their
capability of growing on media supplemented with antibiotics. E. coli K12 and E. coli DH5α
were plated on agar media supplemented with kanamycin (40 μg/mL) as well as ampicillin (100
μg/mL). After 2 days of incubation of the plates at 37˚C, the only growth observed was on the
LB agar plates, where the cells grew to confluency (Figure 18). No colonies appeared on the
agar plates supplemented with antibiotics indicating that the cells incubated with the plasmid did
not uptake it from the media.
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Figure 17. Assessment of bacteria to uptake pKB from liquid media. Cells of each type of strain,
at a concentration of 107 cells/mL, were incubated at 37˚C for 2 days, in 30mL of 1:1 LB to
BG011-SA media along 1000 ng of the pKB plasmid.

54

Figure 18. Plating of cells on selective media to assess natural transformation with pKB. (A) E.
coli K12, (B) E. coli DH5α, and (C) P. putida KT2440 cells that were incubated with 1000ng of
pKB were plated on selective media. The check marks on the top right of each plate indicate that
there was growth observed, whereas the X’s indicates there was no growth observed.
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This is not to suggest that these bacterial strains are not naturally transformable, as there
are reports of natural transformation of E. coli for instance.110 However, natural transformation
of E. coli K12, E. coli DH5α, and P. putida KT2440, specifically with pKB, was not observed
when these experiments were performed in triplicates. Thus, this eliminates the possibility that
the HGT observed is an artifact of uptake of naked DNA from the growth media. It is therefore
concluded that the E. coli K12 colonies (Figure 12A) and E. coli DH5α (Figure 13A) colonies
that grew on kanamycin (40 μg/mL) are a result of gene transfer from the GE T. elongatus BP1
to the bacteria. Verification with PCR further confirms these results (Figure 12C) and Figure
13C).
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CHAPTER IV
CONCLUSIONS AND FUTURE WORK

Curious Case of P. putida KT 2440 and T. elongatus BP1
In summary, this work suggests that HGT of genes conferring antibiotic resistance is
possible from GE cyanobacteria to E. coli K12 and E. coli DH5α. The results for E. coli DH5α
are consistent with those reported by Nguyen et. al.95 However, that is not the case with P. putida
KT2440, in which case no HGT was observed. One factor that this could be due to is that
expression of the plasmids with some of the same characteristics as pKB that was used here has
been found to be unpredictable in P. putida KT2440.111 However, since with direct
transformation into P. putida, the kanamycin resistant genes were able to be expressed, it could
be a mechanism of HGT that is not activated in this case. The abnormal growth on the LB agar
plate were P. putida KT2440 that had grown in co-culture with the GE cyanobacteria were
plated, is a perplexing phenomenon, indicating that the P. putida KT2440 is not tolerating the
cyanobacteria very well. It could be possible that metabolic products secreted by the GE T.
elongatus BP1 are deleterious to the P. putida KT2440. To evaluate whether the GE
cyanobacteria are responsible for excreting metabolic products in their media that prevent the
normal growth of P. putida KT2440 the supernatant of the GE cyanobacteria could be used to
culture Pseudomonas cells in while monitoring their growth.
The control experiment where the uptake of the pKB plasmid by the bacterial strains
from the media is assessed, indicates that it is not possible to occur. This indicates that the HGT
via conjugation that is observed is not an artifact of DNA uptake from the cells by the media.
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Conjugation is a guided process that requires coordination of the donor cyanobacterial cells and
the recipient E. coli cells in the cases where it is observed.
We also observed that in cases when transformation via electroporation was possible,
HGT was not observed and the opposite. For E. coli K12 in particular, while direct
transformation via electroporation with the pKB plasmid was not successful, when grown in coculture with the transformed T. elongatus BP1 cyanobacteria, the cells were able to uptake the
kanamycin resistance genes. It is reported that the transformation of E. coli K12 may be
prevented by the DNase activity that other E. coli strains, such as E. coli DH5a do not present
due to the genetic modification they carry.112 Therefore, HGT of the kanamycin resistance genes
indicates that via conjugation E. coli K12 bacteria are able to uptake genes via conjugation that
could not be directly transformed into them through electroporation. On the other hand, the
Pseudomonas strain is a case where HGT is not observed, despite direct transformation of the
pKB plasmid in the P. putida KT2440 cells having been verified.

Limitations
Limitations of this work arise from our inability to completely mimic environmental
conditions that the cyanobacteria may be found in, having escaped laboratory containment.
However, by lowering the temperature for the growth conditions, in the Percival they are grown
at 45˚C whereas they are incubated at 37˚C for the HGT experiments and incubating them in
media composition that is different from their preferred media we are testing their ability to
survive and transfer genes to other bacterial strains under non-ideal conditions. This type of
thermophilic bacterial strain is not capable of growing at temperatures below 30˚C, therefore
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there is little concern for spreading genes of antibiotic resistance under those conditions. This
way, the thermophilic quality of T. elongatus BP1 serves as a biohazard safeguard.

Future Work
The results of this research make it imperative to design strict biohazard containment
policies and experimental designs, not only when working with GE cyanobacteria that have been
modified for biofuel production in general but for GMO applications and experiments in general.
There should also be laboratory containment policies in place put forth by government agencies
such as the USDA oversighting GMO research that safeguard against the escape of GE bacteria,
as they may pose a threat to human health when genes of antibiotic resistance are part of the
engineering process.
HGT experiments from the E. coli K12 and DH5α cells that were able to uptake the
kanamycin resistance gene from the GE T. elongatus BP1 cyanobacteria to other bacteria would
reveal if secondary HGT events may be observed. Future work also involves the evaluation of
the HGT capabilities of the genes conferring antibiotic resistance from the GE cyanobacteria to
more bacterial strains. Specifically, gram-positive strains will be studied in order to acquire a
deeper understanding of HGT towards different types of bacteria, as well as how these strains
interact with the GE cyanobacteria. Gram-positive bacteria are composed of a thick
peptidoglycan wall and their conjugation processes are different than gram-negative.113
Preliminary experiments are underway with bacterial strains B. licheniformis ATCC 14580 and
S. epidermis ATCC12228. Primers for the identification of the bacterial strains used in the lab
have been designed (Appendix A). This research would shed more light on differences between
HGT among gram-negative and gram-positive bacteria.
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APPENDIX

PRIMER DESIGN FOR IDENTIFICATION OF BACTERIA P. PUTIDA KT2440, S.
EPIDERMIS ATCC 12228, AND B. LICHENIFORMIS ATCC14580

With the introduction of more bacterial strains in the lab, it was fundamental to be able to
distinguish between them using a genetic technique. Primers were designed for P. putida
KT2440 that was used in the HGT experiments as well as Staphylococcus epidermis ATCC
12228 and Bacillus licheniformis ATCC14580, that are intended for future experiments. Genes
were selected based on the characterization previously done on them in the literature. For P.
putida, primers were designed for the gyrase B gene, which in studies by Yamamoto and
Harayama was amplified, sequenced and used for identification of P. putida against E. coli and
Bacillus Subtilis.114 GyrB was selected as the gene to be amplified for the identification of S.
epidermis, as it has been found in its more pathogenic S. aureus relative to be associated with
resistance to antibiotics.115 For B. licheniformis the recF gene was selected that codes for the
recF protein and has been characterized in its relative strain B. subtilis.116
Each of the primer sets (forward and reverse for each bacterial strain) were run on DNA
samples from all the bacterial strains used in the lab to ensure that they amplify the target genes
only in the strains they are expected to positively identify. Thus, the primer for P. putida’s gyrB
resulted in the band at 2.4 kb only for the sample containing DNA from P. putida KT2440, while
it was negative for all other bacterial strains (Figure A1A). Similarly, when the primers designed
for S. epidermis’s gyrB and B. licheniformis’s recF genes, and run through DNA from all the
other bacterial strains, they resulted in a 1.9 kb (Figure A1B) and a 1.1 kb (Figure A1C) band for
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the identification of S. epidermis ATCC 12228 and B. licheniformis ATCC 14580 respectively.
The off-target band in lane D of Figure A1C) is where the primers designed for B. licheniformis
amplified a sequence from S. epidermis. However, because the band in lane D is at 1.2 kb based
on the MW marker, these primers result in positive identification of B. licheniformis ATCC
14580. These results show that the designed primers can be used for the positive identification of
each of the bacterial strains.

Table A1. Primers designed for bacteria strain identification
Bacterial
Strain

P. putida KT2440

S. epidermis ATCC 12228

B. licheniformis ATCC
14580

Gene

GyrB

GyrB

RecF

Forward
Primer
Sequence

ATGAGCGAAAA
TCAAACGTACG
ACTCC

CAGATAATTATGGTGCT
GGACAGATACAAG

TATCGTCTTACCGT
AATTATGAGCG

Reverse
Primer
Sequence

GACAGCGCGTT
AGAAATCTAGGTTGGCA
ACTTTCGATGAA TAAACTGC
GT

TCAGTCCGATAGCG
TGCCATTTTCA

Expected
Band Size
(kb)

2.4

1.1

1.9
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Figure A1. Identification of P. putida KT2440, S. epidermis and B. licheniformis with PCR.
Primers designed for each strain in (A), (B), and (C) were run through DNA from all bacterial
strains used in the lab (A-E): E. coli K12 (samples A), E. coli DH5α (samples B), P. putida
KT2440 (samples C), S. epidermis (samples D), and B. licheniformis (samples E).
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